{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T15:10:02Z","timestamp":1742742602505,"version":"3.40.2"},"reference-count":3,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cytopathology"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>Cytopathology plays a crucial role in the diagnosis and management of lymphocytic effusions, which are fluid collections rich in lymphocytes often associated with conditions like infections, malignancies, and autoimmune diseases. By examining the cytological features of the cells present in the effusion, cytopathologists can help distinguish between benign and malignant processes, identify specific infectious agents, and provide insights into underlying disease mechanisms. This information is vital for guiding treatment decisions and monitoring disease progression, making cytopathology an essential tool in the clinical evaluation of lymphocytic effusions.<\/jats:p>","DOI":"10.1111\/cyt.13448","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T14:13:24Z","timestamp":1728569604000},"page":"201-203","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lymphocytic\u2010rich effusion"],"prefix":"10.1111","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2063-6666","authenticated-orcid":false,"given":"Jaiden","family":"Townsend","sequence":"first","affiliation":[{"name":"UCL Medical school  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5856-1893","authenticated-orcid":false,"given":"Miguel","family":"Perez\u2010Machado","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology Royal Free London NHS Foundation Trust  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2019.08.013"},{"key":"e_1_2_8_3_1","first-page":"31","volume-title":"Blood and Lymphatic Cancer: Targets and Therapy","author":"Berhan A","year":"2022"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030722"}],"container-title":["Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cyt.13448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T14:28:57Z","timestamp":1742740137000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cyt.13448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":3,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1111\/cyt.13448"],"URL":"https:\/\/doi.org\/10.1111\/cyt.13448","archive":["Portico"],"relation":{},"ISSN":["0956-5507","1365-2303"],"issn-type":[{"type":"print","value":"0956-5507"},{"type":"electronic","value":"1365-2303"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"assertion":[{"value":"2024-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}